Results 191 to 200 of about 8,256,452 (300)
Introduction There are no Food and Drug Administration (FDA) approved therapies for Raynaud's phenomenon (RP) treatment in the United States (U.S.). Clinical trials have been challenged by study design. Important advances in RP patient reported outcome measures and mechanistic quantification allows RP‐related pain characterization.
Tracy M Frech +4 more
wiley +1 more source
Fundamental limits on nonequilibrium sensing. [PDF]
Dechant A, Lutz E.
europepmc +1 more source
Objective This systematic review aimed to assess the diagnostic accuracy of algorithms used to identify rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) in electronic health records (EHRs). Methods We searched MEDLINE, Embase, and CENTRAL databases and included studies that validated case definitions against a reference standard such ...
Constanza Saka‐Herrán +10 more
wiley +1 more source
Financial Distress and its Determinants in Rheumatoid Arthritis
Objective To quantify the degree of financial distress and identify its determinants in adults with rheumatoid arthritis (RA) given the frequent chronic use of expensive disease modifying therapies. Methods We identified adults enrolled in the FORWARD databank with either RA or non‐inflammatory musculoskeletal disease (NIMSKD) completing the Functional
Amber Brown Keebler +5 more
wiley +1 more source
Masuda: The Information Society as Post-Industrial Society
Pertti Vuorela
doaj
Civil society active in corporate accountability dataset. [PDF]
Rammelt HP.
europepmc +1 more source
Education and Irish society - with special reference to informational needs
W. J. Hyland
openalex +1 more source

